End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.06 CNY | -1.09% | +0.44% | +0.78% |
Apr. 15 | Luyan Pharma Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
2023 | Luyan Pharma Co.,Ltd. Announces Board Appointments | CI |
Sales 2022 | 19.46B 2.7B | Sales 2023 | 19.85B 2.75B | Capitalization | 3.49B 484M |
---|---|---|---|---|---|
Net income 2022 | 345M 47.8M | Net income 2023 | 364M 50.43M | EV / Sales 2022 | 0.4 x |
Net Debt 2022 | 4.49B 622M | Net Debt 2023 | 4.25B 589M | EV / Sales 2023 | 0.39 x |
P/E ratio 2022 |
9.36
x | P/E ratio 2023 |
9.56
x | Employees | 5,475 |
Yield 2022 |
3.6% | Yield 2023 |
3.34% | Free-Float | 57.22% |
1 day | -1.09% | ||
1 week | +0.44% | ||
Current month | +2.37% | ||
1 month | +12.97% | ||
3 months | +25.14% | ||
6 months | -4.63% | ||
Current year | +0.78% |
Managers | Title | Age | Since |
---|---|---|---|
Jin Xiang Wu
CEO | Chief Executive Officer | 62 | 08-08-31 |
Cong Jin Yang
DFI | Director of Finance/CFO | 55 | 11-10-19 |
Cui Ping Li
BRD | Director/Board Member | 44 | 11-10-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Zhi Yang Lin
BRD | Director/Board Member | 68 | 17-10-18 |
Jin Xiang Wu
CEO | Chief Executive Officer | 62 | 08-08-31 |
Yan Zhao Tang
BRD | Director/Board Member | 56 | 17-10-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 9.06 | -1.09% | 2,784,733 |
24-05-14 | 9.16 | +1.33% | 3,780,613 |
24-05-13 | 9.04 | -1.53% | 4,892,740 |
24-05-10 | 9.18 | +0.22% | 4,186,174 |
24-05-09 | 9.16 | +1.55% | 5,789,135 |
End-of-day quote Shenzhen S.E., May 14, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.78% | 487M | |
+19.52% | 71.69B | |
-2.80% | 23.65B | |
+9.05% | 9.01B | |
+11.24% | 8.64B | |
-18.91% | 8.15B | |
+13.61% | 5.33B | |
+17.83% | 4.35B | |
-2.11% | 4.1B | |
-2.13% | 3.94B |
- Stock Market
- Equities
- 002788 Stock